相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers
Andreas Lau et al.
CELLULAR SIGNALLING (2023)
Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis
Rongxin Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis
Yang Xiao et al.
SCIENCE TRANSLATIONAL MEDICINE (2023)
Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies
Sowmya Mekala et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2023)
An update on animal models of liver fibrosis
ShuTing Wu et al.
FRONTIERS IN MEDICINE (2023)
Tetracycline antibiotics: Potential anticancer drugs
Jiayu Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
Stavros P. Papadakos et al.
CANCERS (2023)
Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future
Scott L. Friedman et al.
HEPATOLOGY (2022)
Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications
Jose Garrido-Mesa et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)
Recovery of gut microbiota in mice exposed to tetracycline hydrochloride and their correlation with host metabolism
Wei Zhao et al.
ECOTOXICOLOGY (2021)
Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain
Mahmoud S. Ahmed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The Development of Third-Generation Tetracycline Antibiotics and New Perspectives
Aura Rusu et al.
PHARMACEUTICS (2021)
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells
Xiaogang Chen et al.
CELL DEATH & DISEASE (2020)
Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis
Brian Wu et al.
CURRENT RHEUMATOLOGY REPORTS (2019)
Eph receptor signalling: from catalytic to non-catalytic functions
Lung-Yu Liang et al.
ONCOGENE (2019)
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
Patrice N. Mimche et al.
SCIENTIFIC REPORTS (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies
Daniel Martinez Molina et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Mechanisms of ephrin-Eph signalling in development, physiology and disease
Artur Kania et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
Kai Qu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Eph Receptors and Ephrins: Therapeutic Opportunities
Antonio Barquilla et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis
Noah S. Butler et al.
HEPATOLOGY (2015)
The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
Patrice N. Mimche et al.
HEPATOLOGY (2015)
Therapeutic targeting of EPH receptors and their ligands
Andrew W. Boyd et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Minocycline: far beyond an antibiotic
N. Garrido-Mesa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Eph/ephrin signaling: Genetic, phosphoproteomic, and transcriptomic approaches
Jeffrey O. Bush et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Anti-inflammatory properties of Doxycycline and Minocycline in experimental models: an in vivo and in vitro comparative study
Liz M. Leite et al.
INFLAMMOPHARMACOLOGY (2011)
Ligand docking and binding site analysis with PyMOL and Autodock/Vina
Daniel Seeliger et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance
I Chopra et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)
Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors
KL Binns et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses
AH Zisch et al.
ONCOGENE (2000)